Niclosamide oral (CNPharm/Hyundai Bioscience)

N/A

Report date: 2026/05/09 20:00:18

Base Information

Drug NameNiclosamide oral (CNPharm/Hyundai Bioscience)
Drug Alias NameNiclosamide dehydrotalcite (CNPharm/Hyundai Bioscience)XaftyCP-COV03Poly-COV01
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionVirus replication inhibitorsWnt signalling pathway inhibitors
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Triple Negative Breast NeoplasmsMonkeypox +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryVietnamSouth Korea
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesHyundai Bioscience Co LtdCNPharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCNPharm Co LtdHyundai Bioscience Co LtdDrugs For Neglected Diseases Initiative
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Triple Negative Breast NeoplasmsMonkeypox +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A